Skip to main content

Global Veterinary Diagnostics Market: Future Technological Trends and 10% CAGR Projected by 2030

 


The global veterinary diagnostics market is projected to grow at a CAGR of approximately 10% during the forecast period. This growth is fueled by the increasing prevalence of animal diseases, advancements in diagnostic technologies, rising pet ownership, and expanding awareness of animal healthcare. However, high costs of diagnostic equipment and limited access to veterinary services in rural areas pose challenges to market expansion.

The veterinary diagnostics market encompasses the tools, techniques, and devices used to detect and monitor diseases in animals, including pets, livestock, and wildlife. It spans diagnostic imaging, molecular diagnostics, immunodiagnostics, and clinical chemistry, which help veterinarians make precise diagnoses and improve animal health outcomes. These diagnostics are crucial for managing zoonotic diseases, ensuring food safety, and enhancing productivity in livestock. Advancements in technology and growing awareness about animal health are driving innovations in this sector

Download a free sample report for in-depth market insights

https://meditechinsights.com/veterinary-diagnostics-market/request-sample/

Impact of Zoonotic Diseases on Veterinary Diagnostics

The increasing prevalence of zoonotic diseases is a significant factor driving growth in the veterinary diagnostics market. According to a National Institutes of Health (NIH) article, approximately 60% of emerging human pathogens and around 75% of all emerging infectious diseases are zoonotic. These staggering figures underscore the importance of understanding human activities' impact on zoonotic disease prevalence and transmission. Early detection and management are crucial to prevent outbreaks like avian influenza and rabies, which pose significant public health risks. This awareness has spurred investments in advanced veterinary diagnostic systems and healthcare infrastructure, particularly in regions vulnerable to zoonotic diseases. By enabling precise monitoring and early intervention, these diagnostic measures are critical for mitigating potential pandemics and ensuring the health of both animals and humans

Technological Innovations Shaping the Veterinary Diagnostics Market

Advancements in diagnostic technologies are revolutionizing the veterinary diagnostics landscape, making disease detection faster, more precise, and more accessible. Point-of-care (POC) diagnostic tools, for instance, allow veterinarians to perform tests on-site and receive immediate results, enhancing treatment efficiency. Molecular diagnostics, such as PCR and next-generation sequencing, have significantly improved the accuracy of detecting pathogens at the genetic level. Artificial intelligence (AI) and machine learning (ML) are also being integrated into diagnostic systems, enabling predictive analytics and personalized treatment plans. Additionally, the rise of portable and user-friendly diagnostic devices ensures that even resource-limited regions can adopt advanced testing methodologies. These innovations not only improve clinical outcomes but also contribute to the proactive management of animal health, addressing critical challenges such as zoonotic disease outbreaks and livestock productivity.

Competitive Landscape Analysis

The global veterinary diagnostics market is marked by the presence of established and emerging market players such as IDEXX Laboratories, Inc.; Zoetis; Antech Diagnostics, Inc.; Agrolabo S.p.A.; Embark Veterinary, Inc.; Esaote SPA; Thermo Fisher Scientific, Inc.; Innovative Diagnostics SAS; Virbac and FUJIFILM Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Unlock key data with a sample report for competitive analysis:

https://meditechinsights.com/veterinary-diagnostics-market/request-sample/

Global Veterinary Diagnostics Market Segmentation

This report by Medi-Tech Insights provides the size of the global veterinary diagnostics market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, test type, animal type and end-user

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Consumables, Reagents & Kits
    • Equipment & Instruments
  • Market Size & Forecast (2023-2030), By Test Type, USD Million
    • Clinical Chemistry
    • Microbiology
    • Parasitology
    • Histopathology
    • Cytopathology
    • Hematology
    • Immunology & Serology
    • Imaging
    • Molecular Diagnostics
    • Others
  • Market Size & Forecast (2023-2030), By Animal Type, USD Million
    • Production Animals
      • Cattle
      • Poultry
      • Swine
      • Others
    • Companion Animals
      • Dogs
      • Cats
      • Horses
      • Others
  • Market Size & Forecast (2023-2030), By End-user, USD Million
    • Veterinary Hospitals & Clinics
    • Animal Owners/ Producers
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

 

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com     

Comments

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...